Oncolytic Adenovirus Service
Oncolytic adenoviruses provide a promising platform for cancer-immunotherapy agents. Since the adenoviral structure and gene function have been well characterized, oncolytic adenoviruses can be easily modified and adapted to increase the selectivity and potency of vector transduction and replication in cancer cells. QVirus™ platform commits to developing efficacious oncolytic adenovirus for customer and enabling wider applications of adenovirus in oncolytic virotherapy of cancers.
Created: 10 Apr 2025 09:04:11 AM
All Replies (0)
There are no replies to this discussion.